PDE10A and ovarian carcinoma: We further demonstrate that PDE10A inhibition leads to an increase in both cAMP/PKA and cGMP/PKG signaling, and the activation of these protein kinases coincides with the growth inhibitory and apoptotic activity of Pf-2545920 and MCI-030 in ovarian cancer cells.